Renata Cristina Picão

Renata Cristina Picão

Auto-generated profile, based on publicly available information

Renata Cristina Picão

Laboratório de Investigação em Microbiologia Médica (LIMM), Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2010 in Expert Review of Anti-infective Therapy
Verified
Journal Article
Closed access
AZAlexandre Zavascki
Alexandre Zavascki
CCCecilia G. Carvalhaes
Cecilia G. Carvalhaes
RPRenata C Picão
Renata C Picão
AGAna Cristina Gales
Ana Cristina Gales
Pseudomonas aeruginosa and Acinetobacter baumannii are major nosocomial pathogens worldwide. Both are intrinsically resistant to many drugs and are able to become resistant to virtually any antimicrobial agent. An increasing prevalence of infections caused by multidrug-resistant (MDR) isolates has been reported in many countries. The resistance mechanisms of P. aeruginosa and A. baumannii include the production of beta-lactamases, efflux pumps, and target-site or outer membrane modifications. Resistance to multiple drugs is usually the result of the combination of different mechanisms in a single isolate or the action of a single potent resistance mechanism. There are many challenges in the treatment of MDR P. aeruginosa and A. baumannii, especially considering the absence of new antimicrobials in the drug-development pipeline. In this review, we present the major resistance mechanisms of P. aeruginosa and A. baumannii, and discuss how they can affect antimicrobial therapy, considering recent clinical, microbiological, pharmacokinetic and pharmacodynamic findings of the main drugs used to treat MDR isolates.

8 December 2009 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
CCCecilia G. Carvalhaes
Cecilia G. Carvalhaes
RPRenata C. Picão
Renata C. Picão
ANAdriana G. Nicoletti
Adriana G. Nicoletti
DXDanilo Xavier
Danilo Xavier
AGAna Cristina Gales
Ana Cristina Gales
The aim of this study was to evaluate the presence of carbapenemases in a Klebsiella pneumoniae collection and the performance of the modified Hodge test (MHT) to correctly identify this phenotype. Twenty-eight K. pneumoniae clinical isolates with reduced susceptibility to carbapenems were evaluated. Antimicrobial susceptibility and molecular typing were performed by agar dilution and PFGE, respectively. The MHT was performed using both standard and high inoculum of test organisms. Imipenem hydrolysis was investigated by spectrophotometric assays and carbapenemase-encoding genes were identified by PCR and amplicon sequencing. Porin loss was investigated by both PCR and SDS–PAGE. Susceptibility rates for imipenem, meropenem and ertapenem were 93%, 57% and 11%, respectively. The PFGE analysis showed seven unrelated genotypes. By testing standard inoculum and ertapenem or meropenem discs, 25% (n = 7) and 21% (n = 6) of the isolates were classified as carbapenemase producers, respectively. When a higher inoculum was employed, these rates increased to 54% (n = 15) and 43% (n = 12), respectively. No imipenem hydrolysis was detected. PCRs identified blaCTX-M in 27 (96%) isolates, of which 2 isolates also carried blaGES-1. SDS–PAGE and PCR assays revealed that all isolates had lost at least one outer membrane protein, except for a single isolate that was found to express both OmpK35 and OmpK36. False detection of carbapenemase production was observed by the MHT possibly as a result of extended-spectrum β-lactamase (ESBL) production coupled with porin loss as reported before. Clinical laboratories must be aware of this fact, especially in geographical areas where ESBL-producing isolates are highly prevalent.

1 May 2013 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
RPRenata C. Picão
Renata C. Picão
JCJuliana P. Cardoso
Juliana P. Cardoso
ECEloiza H. Campana
Eloiza H. Campana
ANAdriana G. Nicoletti
Adriana G. Nicoletti
FPFernanda V.B. Petrolini
Fernanda V.B. Petrolini
AGAna Cristina Gales
Ana Cristina Gales

1 June 2008 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
RPRenata C. Picão
Renata C. Picão
SASoraya S. Andrade
Soraya S. Andrade
ANAdriana Gianinni Nicoletti
Adriana Gianinni Nicoletti
ECEloiza H. Campana
Eloiza H. Campana
GMGabriela C. Moraes
Gabriela C. Moraes
AGAna Cristina Gales
Ana Cristina Gales
The emergence of metallo-β-lactamase (MBL)-producing isolates is a challenge to routine microbiology laboratories, since there are no standardized methods for detecting such isolates. The aim of this study was to evaluate the accuracy of different phenotypic methods to detect MBL production among Pseudomonas spp., Acinetobacter spp., and enterobacterial isolates, including GIM, IMP, SIM, SPM, and VIM variants. A total of 46 genetically unrelated Pseudomonas aeruginosa , Pseudomonas putida , Acinetobacter sp., and enterobacterial strains producing distinct MBLs were tested. Nineteen strains were included as negative controls. The inhibition of bacterial growth and β-lactam hydrolysis caused by MBL inhibitors (IMBL) also were evaluated. The isolates were tested for MBL production by both a double-disk synergy test (DDST) and a combined disk assay (CD) using imipenem and ceftazidime as substrates in combination with distinct IMBL. One hundred percent sensitivity and specificity were achieved by DDST using 2-mercaptopropionic acid in combination with ceftazidime and imipenem for the detection of MBL production among P. aeruginosa and Acinetobacter species isolates, respectively. The CD test showed the same results for detecting MBL-producing enterobacteria by combining imipenem and EDTA, with a 5.0-mm-breakpoint increase in the size of the inhibition zone. Our results indicate that both phenotypic methods to detect MBL-producing isolates should be based on the genera to be tested, regardless of the enzyme produced by such isolates, as well as on the local prevalence of MBL producers.

22 January 2014 in BMC Genomics
Verified
Journal Article
Open access
PDF file
PRPablo Ivan Pereira Ramos
Pablo Ivan Pereira Ramos
RPRenata Christina Picão
Renata Christina Picão
LALuiz G P de Almeida
Luiz G P de Almeida
NLNicholas Costa B Lima
Nicholas Costa B Lima
RGRaquel Girardello
Raquel Girardello
Marisa FABIANA NICOLÁSMarisa FABIANA NICOLÁS
Marisa FABIANA NICOLÁS
Klebsiella pneumoniae is an important opportunistic pathogen associated with nosocomial and community-acquired infections. A wide repertoire of virulence and antimicrobial resistance genes is present in K. pneumoniae genomes, which can constitute extra challenges in the treatment of infections caused by some strains. K. pneumoniae Kp13 is a multidrug-resistant strain responsible for causing a large nosocomial outbreak in a teaching hospital located in Southern Brazil. Kp13 produces K. pneumoniae carbapenemase (KPC-2) but is unrelated to isolates belonging to ST 258 and ST 11, the main clusters associated with the worldwide dissemination of KPC-producing K. pneumoniae. In this report, we perform a genomic comparison between Kp13 and each of the following three K. pneumoniae genomes: MGH 78578, NTUH-K2044 and 342.

1 September 2009 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
RPRenata C. Picão
Renata C. Picão
LPLaurent Poirel
Laurent Poirel
AGAna Cristina Gales
Ana Cristina Gales
PNPatrice Nordmann
Patrice Nordmann
A retrospective survey was conducted to characterize β-lactamases in a collection of 43 ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from patients with bloodstream infections hospitalized at a Brazilian teaching hospital between January and December 2005. Resistance rates for carbapenems, aminoglycosides, and quinolones were over 80%, with only colistin remaining active against all isolates. Pulsed-field gel electrophoresis analysis identified seven different genotypes. AmpC overproduction was found to be the sole β-lactamase-mediated mechanism responsible for ceftazidime resistance in four isolates (9.3%). Nine isolates (20.9%) produced an extended-spectrum β-lactamase (ESBL), either GES-1 ( n = 7, 16.3%) or CTX-M-2 ( n = 2, 4.6%). Carbapenemase activity was detected in 30 (70%) additional isolates. Among those isolates, two isolates (4.6%) produced the ESBL GES-5, possessing the ability to hydrolyze imipenem; a single isolate (2.3%) produced the metallo-β-lactamase (MBL) IMP-1; and 27 isolates produced the MBL SPM-1 (62.8%). None of the isolates coproduced both ESBL and MBL. Insertion sequence elements IS CR4 and IS CR1 were associated with bla SPM-1 and bla CTX-M-2 genes, respectively, whereas the bla GES-1 and bla GES-5 genes were part of class 1 integron structures. This study underlines the spread of MBL- and ESBL-producing P. aeruginosa isolates as an important source of ceftazidime resistance in Brazil.